SG Americas Securities’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.59M | Sell |
47,107
-22,641
| -32% | -$927K | ﹤0.01% | 1381 |
|
|
2026
Q1 | $2.32M | Sell |
69,748
-8,609
| -11% | -$257K | ﹤0.01% | 1321 |
|
|
2025
Q4 | $2.34M | Buy |
78,357
+16,982
| +28% | +$555K | ﹤0.01% | 1438 |
|
|
2025
Q3 | $2.22M | Buy |
61,375
+52,086
| +561% | +$1.72M | 0.01% | 894 |
|
|
2025
Q2 | $334K | Buy |
9,289
+6,088
| +190% | +$227K | ﹤0.01% | 1931 |
|
|
2025
Q1 | $126K | Sell |
3,201
-4,529
| -59% | -$152K | ﹤0.01% | 2880 |
|
|
2024
Q4 | $233K | Sell |
7,730
-15,884
| -67% | -$456K | ﹤0.01% | 2012 |
|
|
2024
Q3 | $552K | Buy |
23,614
+15,238
| +182% | +$333K | ﹤0.01% | 1601 |
|
|
2024
Q2 | $149K | Sell |
8,376
-6,682
| -44% | -$107K | ﹤0.01% | 2330 |
|
|
2024
Q1 | $229K | Sell |
15,058
-5,161
| -26% | -$82.2K | ﹤0.01% | 1878 |
|
|
2023
Q4 | $345K | Buy |
+20,219
| New | +$235K | ﹤0.01% | 1714 |
|
|
2023
Q2 | – | Sell |
-197,884
| Closed | -$2.98M | – | 3133 |
|
|
2023
Q1 | $2.98M | Buy |
+197,884
| New | +$3.01M | 0.03% | 469 |
|
|
2022
Q4 | – | Sell |
-66,443
| Closed | -$393K | – | 3370 |
|
|
2022
Q3 | $393K | Buy |
+66,443
| New | +$436K | ﹤0.01% | 1761 |
|
|
2022
Q1 | – | Sell |
-12,020
| Closed | -$228K | – | 3424 |
|
|
2021
Q4 | $228K | Sell |
12,020
-9,876
| -45% | -$256K | ﹤0.01% | 2605 |
|
|
2021
Q3 | $729K | Buy |
21,896
+16,306
| +292% | +$504K | ﹤0.01% | 2182 |
|
|
2021
Q2 | $217K | Sell |
5,590
-16,022
| -74% | -$629K | ﹤0.01% | 2302 |
|
|
2021
Q1 | $1.04M | Buy |
21,612
+10,009
| +86% | +$481K | 0.01% | 1514 |
|
|
2020
Q4 | $604K | Sell |
11,603
-40,908
| -78% | -$1.38M | ﹤0.01% | 1845 |
|
|
2020
Q3 | $1.41M | Buy |
52,511
+38,866
| +285% | +$894K | 0.01% | 992 |
|
|
2020
Q2 | $266K | Sell |
13,645
-3,208
| -19% | -$51.7K | ﹤0.01% | 2614 |
|
|
2020
Q1 | $166K | Buy |
+16,853
| New | +$213K | ﹤0.01% | 2646 |
|
|
2019
Q4 | – | Sell |
-27,266
| Closed | -$153K | – | 3435 |
|
|
2019
Q3 | $153K | Sell |
27,266
-3,592
| -12% | -$25K | ﹤0.01% | 2499 |
|
|
2019
Q2 | $267K | Buy |
30,858
+1,481
| +5% | +$11.2K | ﹤0.01% | 2253 |
|
|
2019
Q1 | $236K | Sell |
29,377
-8,908
| -23% | -$48.1K | ﹤0.01% | 2450 |
|
|
2018
Q4 | $157K | Buy |
38,285
+23,263
| +155% | +$116K | ﹤0.01% | 2504 |
|
|
2018
Q3 | $84K | Buy |
+15,022
| New | +$172K | ﹤0.01% | 2905 |
|
|
2015
Q1 | – | Sell |
-6,905
| Closed | -$109K | – | 3041 |
|
|
2014
Q4 | $109K | Buy |
+6,905
| New | +$89.9K | ﹤0.01% | 2863 |
|
Other funds holding TGTX
SCM
CAM
SG Americas Securities's TGTX Position: Q2 2026 in Review
SG Americas Securities reduced its TG Therapeutics (TGTX) stake by 32% in Q2 2026, selling an estimated $927K and leaving 47,107 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.
SG Americas Securities first reported a position in TGTX in Q4 2014 and has held it in 27 quarters since. The position peaked at $2.98M in Q1 2023. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- SG Americas Securities held 47,107 shares of TG Therapeutics worth $2.59M as of Q2 2026.
- SG Americas Securities sold 22,641 TG Therapeutics shares in Q2 2026, an estimated $927K.
- TG Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1381 holding.
- SG Americas Securities first reported a position in TG Therapeutics in Q4 2014 and has held it in 27 quarters since.
- SG Americas Securities's TG Therapeutics position peaked at $2.98M in Q1 2023.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.